Synlait Milk (ASX:SM1) share price on watch after FY 2020 profit decline

The Synlait Milk Ltd (ASX:SM1) share price will be on watch this morning after the release of its FY 2020 results…

| More on:
asx share price rise signified by baby with wide eyes and mouth signifying surprise

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Synlait Milk Ltd (ASX: SM1) share price will be on watch on the Monday following the release of its full year results.

How did Synlait Milk perform in FY 2020?

For the 12 months ended 31 July 2020, the dairy processor reported a 27% increase in revenue to NZ$1.3 billion.

This was driven by a 15% increase in consumer-packaged infant formula sales to 49,180 MT and a 46% lift in lactoferrin sales to 30 MT.

Margin contraction from a higher cost base led to Synlait's earnings before interest, tax, depreciation, and amortisation (EBITDA) not increasing in line with sales. It rose 13% to NZ$171.4 million in FY 2020.

Things were worse on the bottom line, with the company's net profit after tax falling 9% to NZ$75.2 million.

Resilient performance.

Synlait's Chair, Graeme Milne, commented: "Synlait's financial performance was resilient when viewed against the backdrop of COVID-19. The company remains solid and highly profitable with EBITDA growing strongly demonstrating the strength of our core infant and lactoferrin businesses."

Mr Milne notes that its profits were down in FY 2020 due to the company investing in its future growth. He appears confident these investments will create long term value for shareholders.

He explained: "Our NPAT performance did reduce reflecting investments made in new facilities and acquisitions over the past two years to achieve our growth ambitions. We are however well positioned to grow earnings off our current asset base."

The company's CEO, Leon Clement, echoed this sentiment and appears positive on the future.

Mr Clement commented: "Synlait is focused on building a sustainable, diverse and recurring earnings base that comes from multiple customers, sites, markets and categories."

"We are achieving this while balancing the needs of people, planet and profit in our decisions, and responding to changing customer demand against the backdrop of COVID-19. Our strategy to create a strong, diverse company, is more relevant than ever given the uncertain world ahead. Our team delivered a strong result in an exceptional year," he added.

Outlook.

In light of the uncertain economic environment, at this point the company is targeting a similar or slightly improved profit result in FY 2021.

A further update will be provided at Synlait's half year result in March 2021.

Elsewhere in the industry, this morning A2 Milk Company Ltd (ASX: A2M) warned of tough trading conditions in the daigou channel for infant formula sales. It is one of Synlait's largest customers.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »